Genomic insights and evaluation of Bacillus spizizenii Endophyte from Solanum elaeagnifolium Cav against multidrug-resistant pathogens
Frontiers in Cellular and Infection Microbiology · 2026
DOI: 10.3389/fcimb.2026.1929148 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2026. Verfasst von Merihan S Sabra und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, Faculty of Pharmacy, October 6 University, Giza, Egypt. Hauptthemen laut MEDLINE: Endophytes, Solanum, Bacillus. Die Arbeit nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Secondary metabolites are promising alternatives due to their diverse biological activities, including antimicrobial and antiviral effects. Wild plants, particularly Solanum elaeagnifolium Cav (Silverleaf Nightshade), harbor endophytic microorganisms that represent an untapped source of such bioactive compounds. In the present study, four bacterial endophytes were isolated from the leaves of Solanum elaeagnifolium Cav (LS1, LS2, LS3, and LS4), and their extracts (S1, S2, S3, and S4) were prepared. Extract S4 showed both qualitative and quantitative inhibitory activity against a broad range of standard and multidrug-resistant (MDR) pathogens, including Gram-positive and Gram-negative pathogens. Moreover, it showed significant antiviral effects against Adenovirus serotype 7 and Herpes Simplex Viruses 1 and 2. The endophytic bacterium LS4 was identified microscopically, biochemically, and via whole-genome sequencing as Bacillus spizizenii CCASU-2025-89. Cytotoxic assessment of S4 revealed a CC 50 of 80.71 μg/mL and a safe concentration of 6.23 μg/mL. Whole-genome analysis revealed conserved biosynthetic gene clusters of antimicrobial peptides including bacilysin, subtilin, mycosubtilin, bacillaene, bacillibactin, subtilosin A, and Pulcherriminic acid. Overall, this study demonstrates that endophytic bacterium Bacillus spizizenii from Solanum elaeagnifolium represents a promising resource for developing new antimicrobial and antiviral therapeutics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology and Immunology, Faculty of Pharmacy, October 6 University, Giza, Egypt.
- Department of Microbiology and Immunology, Faculty of Pharmacy, Ain Shams University, Cairo, Egypt.
- Innovation Centre in Agritechnology in Advanced Bioprocessing (ICA), Universiti Teknologi Malaysia, Higher Education Hup, Pagoh, Johor, Malaysia.
- Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
Zitieren
APA
Sabra, M. S., Abdel-Hafez, L. J. M., Bishr, A. S., El Enshasy, H. A., Al-Agamy, M. H., Alyahya, K., & Aboshanab, K. M. (2026). Genomic insights and evaluation of Bacillus spizizenii Endophyte from Solanum elaeagnifolium Cav against multidrug-resistant pathogens. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2026.1929148
Vancouver
Sabra MS, Abdel-Hafez LJM, Bishr AS, El Enshasy HA, Al-Agamy MH, Alyahya K, et al. Genomic insights and evaluation of Bacillus spizizenii Endophyte from Solanum elaeagnifolium Cav against multidrug-resistant pathogens. Frontiers in Cellular and Infection Microbiology. 2026. doi:10.3389/fcimb.2026.1929148
BibTeX
@article{Sabra2026,
author = {Sabra, Merihan S and Abdel-Hafez, Lina Jamil M and Bishr, Amr S and El Enshasy, Hesham Ali and Al-Agamy, Mohamed H and Alyahya, Khalid and Aboshanab, Khaled M},
title = {Genomic insights and evaluation of Bacillus spizizenii Endophyte from Solanum elaeagnifolium Cav against multidrug-resistant pathogens},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2026},
doi = {10.3389/fcimb.2026.1929148}
}
EUVIMED